Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Siemens’ ELF test demonstrates accuracy in new study

Siemens’ ELF test demonstrates accuracy in new study

23rd July 2010

Siemens’ enhanced liver fibrosis (ELF) testing system for assessing hepatitis C patients has demonstrated its accuracy in a newly-published study.

Researchers conducted a study which evaluated a simplified version of ELF containing HA, TIMP-1 and PIIINP assayed on Siemens’ Immuno 1 immunoanalyser in comparison with biopsy-based methods.

The study, results of which appeared in the Journal of Viral Hepatitis, showed that the ELF system was accurate in terms of acceptable false-negative and positive rates.

It was also suggested that ELF testing is preferable due to the invasive and potentially risky nature of biopsy, as well as the subjectivity of the results it provides.

The investigators said: “More biopsies can be avoided if error rates comparable to those widely accepted for liver biopsy are tolerated.”

Earlier this month, Siemens launched the Advia Centaur free prostate-specific antigen testing range in Europe, which is designed to assist in the diagnosis of prostate cancer.ADNFCR-8000103-ID-800004595-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.